UK cost agency queries value of 492,000 pound-a-year Alexion drug
0
LONDON (Reuters) - An enzyme treatment from Alexion Pharmaceuticals costing 491,992 pounds a year may be worth using in babies with a rare disorder but does not represent good value for all patients, Britain's healthcare cost watchdog said.